These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22078327)

  • 41. Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.
    Jin Y; Zhang J; Zhu H; Fan G; Zhou G
    Cancer Med; 2020 May; 9(9):3163-3173. PubMed ID: 32154662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.
    Darby S; Murphy T; Thomas H; Robson CN; Leung HY; Mathers ME; Gnanapragasam VJ
    Br J Cancer; 2009 Dec; 101(11):1891-9. PubMed ID: 19888221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
    Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
    Barrett CS; Millena AC; Khan SA
    Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.
    Höll M; Koziel R; Schäfer G; Pircher H; Pauck A; Hermann M; Klocker H; Jansen-Dürr P; Sampson N
    Mol Carcinog; 2016 Jan; 55(1):27-39. PubMed ID: 25559363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation.
    Hadari YR; Kouhara H; Lax I; Schlessinger J
    Mol Cell Biol; 1998 Jul; 18(7):3966-73. PubMed ID: 9632781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
    Vandsemb EN; Bertilsson H; Abdollahi P; Størkersen Ø; Våtsveen TK; Rye MB; Rø TB; Børset M; Slørdahl TS
    J Transl Med; 2016 Mar; 14():71. PubMed ID: 26975394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crosstalk between p38 and Erk 1/2 in Downregulation of FGF1-Induced Signaling.
    Zakrzewska M; Opalinski L; Haugsten EM; Otlewski J; Wiedlocha A
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
    Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
    Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influence of phosphoprotein associated with glycosphingolipid microdomains 1 on biologic behavior of human prostatic cancer cell line in-vitro].
    Yu WJ; Wang YW; You JF; Wang JL; Cui XL; Pei F; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):615-20. PubMed ID: 21092590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
    Zheng C; Yinghao S; Li J
    Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
    Xie Y; Gu J; Qin Z; Ren Z; Wang Y; Shi H; Chen B
    Cell Biochem Funct; 2020 Dec; 38(8):1006-1016. PubMed ID: 32430927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. βKlotho inhibits androgen/androgen receptor‑associated epithelial‑mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling.
    Liu Z; Zhang H; Ding S; Qi S; Liu S; Sun D; Dong W; Yin L; Li M; Zhao X; Lu J
    Oncol Rep; 2018 Jul; 40(1):217-225. PubMed ID: 29749458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression.
    Chen PY; Simons M; Friesel R
    J Biol Chem; 2009 Jun; 284(23):15980-92. PubMed ID: 19339244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of lncRNA ZFAS1 promotes lung adenocarcinoma progression by sponging miR-1271-5p and upregulating FRS2.
    Fan G; Jiao J; Shen F; Chu F
    Thorac Cancer; 2020 Aug; 11(8):2178-2187. PubMed ID: 32515146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Wang L; Lu J; Wu H; Wang L; Liang X; Liang Z; Liu T
    Diagn Pathol; 2017 May; 12(1):42. PubMed ID: 28558797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HAX-1 inhibits apoptosis in prostate cancer through the suppression of caspase-9 activation.
    Yan J; Ma C; Cheng J; Li Z; Liu C
    Oncol Rep; 2015 Nov; 34(5):2776-81. PubMed ID: 26323553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.
    Li J; Ye L; Kynaston HG; Jiang WG
    Int J Oncol; 2012 Feb; 40(2):544-50. PubMed ID: 22076499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.